Fig. 2From: Data-driven identification of endophenotypes of Alzheimer’s disease progression: implications for clinical trials and therapeutic interventionsBaseline characteristics that are significantly different between the latent classes (subgroups of patients) identified from clinical trial/study data. Grey lines depict significantly different class pairs (determined by post-hoc analysis). ADAS-cog Alzheimer’s Disease Assessment Scale—cognitive subscaleBack to article page